InfuSystem Holdings INFU
NYSE INFU
$12.21 +0.01 (+0.08%)
At close: Aug 21, 2026 · 4:00 PM EDT

InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026)

InfuSystem Holdings' (INFU) quarterly Asset Writedowns and Impairment came in at $202000.0 in Q1 2026, down 21.4% YoY from $257000.0 in Q1 2025, and down 51.56% on a QoQ basis from $417000.0 in Q4 2025.

InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends

InfuSystem Holdings (INFU) has 11 years of Asset Writedowns and Impairment data on file, last reported at $202000.0 in Q1 2026.

  • Quarterly Asset Writedowns and Impairment fell 21.4% year-over-year to $202000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464000.0 (up 110.91% YoY) and the FY2025 annual result came in at $519000.0, up 410.78% from the prior year.
  • Asset Writedowns and Impairment retreated to $202000.0 in Q1 2026, from $417000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $450000.0 in Q1 2023 to a low of -$845000.0 in Q4 2024.
  • A 5-year average of $90058.8 and a median of $171000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment tumbled 1000.0% — and 2024, when it surged 765.67%.
  • Tracing INFU's Asset Writedowns and Impairment over 5 years: stood at $171000.0 in 2022, then soared by 161.99% to $448000.0 in 2023, then tumbled by 288.62% to -$845000.0 in 2024, then surged by 149.35% to $417000.0 in 2025, then sank by 51.56% to $202000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $202000.0 (Q1 2026), $417000.0 (Q4 2025), and $63000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 InfuSystem Holdings 244.87 Mn 243.90 Mn 21.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Jun 30, 2026 300,000.00
Mar 31, 2026 202,000.00
Mar 31, 2026 202,000.00
Dec 31, 2025 417,000.00
Dec 31, 2025 417,000.00
Sep 30, 2025 63,000.00
Sep 30, 2025 63,000.00
Jun 30, 2025 -218,000.00
Jun 30, 2025 -218,000.00
Mar 31, 2025 257,000.00
Mar 31, 2025 257,000.00
Dec 31, 2024 -845,000.00
Dec 31, 2024 -845,000.00
Sep 30, 2024 362,000.00
Sep 30, 2024 362,000.00
Jun 30, 2024 446,000.00
Jun 30, 2024 446,000.00
Mar 31, 2024 -130,000.00
Mar 31, 2024 -130,000.00